Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions

被引:45
作者
Duraiswamy, J
Burrows, JM
Bharadwaj, M
Burrows, SR
Cooper, L
Pimtanothai, N
Khanna, R
机构
[1] Queensland Inst Med Res, Div Infect Dis & Immunol, Tumour Immunol Lab, Cooperat Res Ctr Vaccine Technol, Brisbane, Qld 4029, Australia
[2] Univ Queensland, Dept Mol & Cellular Pathol, Joint Oncol Program, Brisbane, Qld 4029, Australia
[3] Chulalongkorn Univ, Fac Med, Dept Microbiol, Immunol Unit, Bangkok 10330, Thailand
关键词
D O I
10.1128/JVI.77.13.7401-7410.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Epstein-Barr virus (EBV)-encoded oncogene latent membrane protein (LMP) 1, which is consistently expressed in multiple EBV-associated malignancies, has been proposed as a potential target antigen for any future vaccine designed to control these malignancies. However, the high degree of genetic variation in the LMP1 sequence has been considered a major impediment for its use as a potential immunotherapeutic target for the treatment of EBV-associated malignancies. In the present study, we have employed a highly efficient strategy, based on ex vivo functional assays, to conduct an extensive sequence-wide analysis of LMP1-specific T-cell responses in a large panel of healthy virus carriers of diverse ethnic origin and nasopharyngeal carcinoma patients. By comparing the frequencies of T cells specific for overlapping peptides spanning LMP1, we mapped a number of novel HLA class I- and class II-restricted LMP1 T-cell epitopes, including an epitope with dual HLA class I restriction. More importantly, extensive sequence analysis of LMP1 revealed that the majority of the T-cell epitopes were highly conserved in EBV isolates from Caucasian, Papua New Guinean, African, and Southeast Asian populations, while unique geographically constrained genetic variation was observed within one HLA A2 supertype-restricted epitope. These findings indicate that conserved LMP1 epitopes should be considered in designing epitope-based immunotherapeutic strategies against EBV-associated malignancies in different ethnic populations.
引用
收藏
页码:7401 / 7410
页数:10
相关论文
共 26 条
  • [11] Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases
    Khanna, R
    Burrows, SR
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, 2000, 54 : 19 - 48
  • [12] Differential splicing of antigen-encoding RNA reduces endogenous epitope presentation that regulates the expansion and cytotoxicity of T cells
    Kienzle, N
    Buck, M
    Silins, SL
    Burrows, SR
    Moss, DJ
    Winterhalter, A
    Brooks, A
    Khanna, R
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (04) : 1840 - 1846
  • [13] Lee SP, 1997, J IMMUNOL, V158, P3325
  • [14] Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4+ T-helper 1 responses
    Leen, A
    Meij, P
    Redchenko, I
    Middeldorp, R
    Bloemena, E
    Rickinson, A
    Blake, N
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (18) : 8649 - 8659
  • [15] INHIBITION OF ANTIGEN-PROCESSING BY THE INTERNAL REPEAT REGION OF THE EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-1
    LEVITSKAYA, J
    CORAM, M
    LEVITSKY, V
    IMREH, S
    STEIGERWALDMULLEN, PM
    KLEIN, G
    KURILLA, MG
    MASUCCI, MG
    [J]. NATURE, 1995, 375 (6533) : 685 - 688
  • [16] Identification and prevalence of CD8+ T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2
    Meij, P
    Leen, A
    Rickinson, AB
    Verkoeijen, S
    Vervoort, MBHJ
    Bloemena, E
    Middeldorp, JM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (01) : 93 - 99
  • [17] SEQUENCE VARIATION IN THE EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN-1
    MILLER, WE
    EDWARDS, RH
    WALLING, DM
    RAABTRAUB, N
    [J]. JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 2729 - 2740
  • [18] CYTO-TOXIC T-CELL CLONES DISCRIMINATE BETWEEN A-TYPE AND B-TYPE EPSTEIN-BARR VIRUS TRANSFORMANTS
    MOSS, DJ
    MISKO, IS
    BURROWS, SR
    BURMAN, K
    MCCARTHY, R
    SCULLEY, TB
    [J]. NATURE, 1988, 331 (6158) : 719 - 721
  • [19] IDENTIFICATION OF TARGET ANTIGENS FOR THE HUMAN CYTOTOXIC T-CELL RESPONSE TO EPSTEIN-BARR-VIRUS (EBV) - IMPLICATIONS FOR THE IMMUNE CONTROL OF EBV-POSITIVE MALIGNANCIES
    MURRAY, RJ
    KURILLA, MG
    BROOKS, JM
    THOMAS, WA
    ROWE, M
    KIEFF, E
    RICKINSON, AB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) : 157 - 168
  • [20] Rickinson A., 1996, FIELDS VIROL, V2, P2397